09:30 AM EST - Bioniche Life Sciences Inc. : reported a narrower loss in its second quarter, helped by enhanced revenues. Net loss for the secondquarter was $2.65 million or $0.03 per share, significantly lower than prior-year's net loss of $4.21 million or $0.07 per share. Consolidated revenues for recent quarter totaled $8.6 million, up 32 per cent from the $6.5 million recorded in the same period a year ago. Bioniche Life Sciences Inc.
shares T.BNC are trading down $0.005 at $0.45.
